Wind River Unveils Wind River Platform for Medical Devices

Wind River, a provider of embedded and mobile software, announced the launch of Wind River Platform for Medical Devices, designed to accelerate the development of medical devices including those requiring premarket notification, U.S. Food and Drug Administration’s (FDA) 510(k), or the more stringent Premarket Approval.

A part of its comprehensive software portfolio, Wind River Platform for Medical Devices is a commercial off-the-shelf (COTS) development and run-time platform enabling safety and security for medical devices, company officials said.

Wind River Platform for Medical Devices is built on Wind River’s VxWorks, a leading real-time operating system (RTOS) designed for use in regulated medical devices that demand the highest levels of safety, reliability and performance.

“Software has become the key differentiator for medical device manufacturers, and with the Wind River Platform for Medical Devices, along with our comprehensive technology portfolio, we are uniquely qualified to help companies meet relevant safety requirements and standardize on open platforms, while taking advantage of next-generation technologies,” said Santhosh Nair, director of medical solutions at Wind River, in a statement.

Wind River sees great opportunity in medical market segment. The company has recorded 30 percent year-over-year growth in this segment. “Wind River Platform for Medical Devices is the first in a series of related product introductions and enhancements for medical device manufacturers on our roadmap to address this exciting growth,” Nair added.

Wind River Platform for Medical Devices also features Wind River Workbench, a collection of embedded software development tools, as well as critical networking and middleware run-time technologies, such as IPsec, SSL, IPv6 and USB.

With VxWorks at the core of the platform, medical device developers can focus on differentiation, while leveraging the core foundational elements of small footprint, determinism, scalability, and high performance, the company said.  

The platform also features components that are prepared in accordance with FDA quality system regulation 21CFR820.50 Purchasing Controls. An example of this is the vendor qualification summary (VQS), which includes documented descriptions of the controls and processes Wind River uses to design and develop its platform components.

In a related development, Wind River announced the latest version of its Wind River Network Acceleration Platform, designed to deliver ultrafast networking performance for network infrastructure equipment.